Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
6.05
-0.80 (-11.68%)
At close: Apr 23, 2025, 4:00 PM
6.03
-0.02 (-0.33%)
Pre-market: Apr 24, 2025, 5:17 AM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $39.82 million as of April 24, 2025. Its market cap has increased by 56.77% in one year.
Market Cap
39.82M
Enterprise Value
-18.55M
1-Year Change
56.77%
Ranking
Category
Stock Price
$6.05
Market Cap Chart
Since April 13, 2017, Forte Biosciences's market cap has decreased from $213.50M to $39.82M, a decrease of -81.35%. That is a compound annual growth rate of -18.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 45.10M | 35.84% |
| Dec 31, 2024 | 33.20M | 11.04% |
| Dec 29, 2023 | 29.90M | 42.38% |
| Dec 30, 2022 | 21.00M | -33.54% |
| Dec 31, 2021 | 31.60M | -93.24% |
| Dec 31, 2020 | 467.20M | 3,578.74% |
| Dec 31, 2019 | 12.70M | -92.25% |
| Dec 31, 2018 | 163.80M | -19.31% |
| Dec 29, 2017 | 203.00M | -4.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.00B |
| UnitedHealth Group | 389.48B |
| Johnson & Johnson | 372.78B |
| AbbVie | 311.94B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.49B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |